| Hematopoietic and Lymphoid Cell Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 349show all (up to 200) |
|---|
| → investigated in trials for | Cyclophosphamidesmall_molecule 891 trials (225 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 891 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dexamethasonesmall molecule 878 trials (266 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 878 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 711 trials (138 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 711 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 699 trials (168 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 699 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 510 trials (158 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 510 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 457 trials (102 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 457 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 387 trials (159 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 387 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall_molecule 374 trials (230 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 374 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal_antibody 341 trials (83 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 341 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 319 trials (54 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 319 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall molecule 317 trials (55 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 317 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall molecule 316 trials (59 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 316 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 269 trials (46 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 269 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 253 trials (23 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 253 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 226 trials (66 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 226 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 221 trials (119 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 194 trials (47 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 194 trials (80 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 194 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall molecule 192 trials (57 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 192 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall_molecule 191 trials (60 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 191 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 188 trials (48 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 188 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 177 trials (68 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 177 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 163 trials (29 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 163 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 121 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 121 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 107 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 99 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 99 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 97 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 97 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 90 trials (26 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 90 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall_molecule 84 trials (27 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 84 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemtuzumab Ozogamicinadc 83 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal_antibody 82 trials (25 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 82 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 79 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 79 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 79 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall molecule 78 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 78 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 78 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall_molecule 76 trials (37 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 76 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 74 trials (19 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 74 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 73 trials (34 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 72 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 72 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 70 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 70 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 68 trials (16 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 68 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 65 trials (44 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 65 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 64 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 61 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 61 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 60 trials (40 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 60 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 59 trials (45 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 59 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 58 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 58 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 58 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 57 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 57 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 55 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall_molecule 55 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 55 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gilteritinibsmall molecule 51 trials (27 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 51 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 50 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 49 trials (15 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 49 trials (44 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 49 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 48 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 48 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 44 trials (35 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 44 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 44 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 43 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall molecule 39 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 38 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 38 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 38 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 37 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 36 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Midostaurinsmall molecule 35 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 35 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 35 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 34 trials (29 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 32 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 31 trials (9 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Quizartinibsmall molecule 31 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 30 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall molecule 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 28 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinibsmall molecule 28 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 26 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 25 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 25 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ivosidenibsmall molecule 25 trials (20 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 25 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 25 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 24 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 23 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 23 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nilotinibsmall molecule 23 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Revumenibsmall molecule 23 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 22 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 22 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 22 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall molecule 22 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 21 trials (18 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxyureasmall molecule 21 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 21 trials (17 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 21 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 21 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 20 trials (12 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 20 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Omacetaxine Mepesuccinatesmall molecule 20 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 19 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall_molecule 19 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 18 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tagraxofuspother 18 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 18 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 17 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 15 trials (13 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 15 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 15 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 15 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 15 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 13 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 13 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 13 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bosutinibsmall molecule 12 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 12 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glasdegibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 12 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ropeginterferon Alfa-2bother 12 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 12 trials (10 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall molecule 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Volasertibsmall molecule 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ziftomenibsmall molecule 12 trials (11 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 11 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 11 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 10 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avapritinibsmall molecule 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 9 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 9 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Donor Lymphocyte Infusion 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Guadecitabinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 9 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 9 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 9 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talazoparibsmall molecule 8 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 7 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olutasidenibsmall molecule 7 trials (7 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 7 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Amsacrinesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crenolanibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dacarbazinesmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Peginterferon Alfa-2bother 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Veliparibsmall molecule 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall_molecule 6 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinblastinesmall molecule 6 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Barasertibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fedratinibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lestaurtinibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mocetinostatsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall_molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sonidegibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal_antibody 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asciminibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azathioprinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | HyperCVAD Regimen 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Regorafenibsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rigosertibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 3 | Observed | clinicaltrials | graph → |